These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8937845)

  • 1. Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae.
    Jones RN; Cormican MG; Wanger A
    Diagn Microbiol Infect Dis; 1996 Aug; 25(4):201-4. PubMed ID: 8937845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs].
    Mihajlović-Ukropina M; Milutinović M
    Med Pregl; 1998; 51(3-4):169-73. PubMed ID: 9611963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.
    Montanari MP; Mingoia M; Giovanetti E; Varaldo PE
    J Clin Microbiol; 2001 Apr; 39(4):1311-5. PubMed ID: 11283047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
    Zhao TM; Liu YN
    Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUSCEPTIBILITY OF RESPIRATORY ISOLATES OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM CHILDREN HOSPITALIZED IN THE CLINICAL CENTER NIS.
    Dinić MM; Mladenović Antić S; Kocić B; Stanković Dordević D; Vrbić M; Bogdanović M
    Med Pregl; 2016; 69(3-4):110-4. PubMed ID: 27506099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and phenotypes of erythromycin-resistant Streptococcus pneumoniae in Shanghai, China.
    Wang M; Zhang Y; Zhu D; Wang F
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):187-9. PubMed ID: 11337187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece.
    Syrogiannopoulos GA; Grivea IN; Beratis NG; Spiliopoulou AE; Fasola EL; Bajaksouzian S; Appelbaum PC; Jacobs MR
    Clin Infect Dis; 1997 Aug; 25(2):188-94. PubMed ID: 9332508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
    Yang H; Shen XZ; Wang YH; Yuan L; Yu SJ; Yang YH
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):936-9. PubMed ID: 15733368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
    Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M
    Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
    Megged O; Assous M; Weinberg G; Schlesinger Y
    Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
    Sener B; Köseoglu O; Gür D; Bryskier A
    J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial activities of clindamycin against clinical isolated Streptococcus pneumoniae].
    Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K
    Jpn J Antibiot; 1997 Nov; 50(11):878-86. PubMed ID: 9651606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance to antibiotics of Streptococcus pneumoniae strains].
    Janicka G; Mikucka A; Białek M; Gospodarek E; Kania I; Rózycka B; Krawiecka D; Wojak I; Kruszyńska E
    Pol Merkur Lekarski; 1997 Nov; 3(17):231-3. PubMed ID: 9523479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin.
    Jacobs MR; Mithal Y; Robins-Browne RM; Gaspar MN; Koornhof HJ
    Antimicrob Agents Chemother; 1979 Aug; 16(2):190-7. PubMed ID: 39493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
    Biedenbach D; Wanger A; Jones RN
    J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
    Descheemaeker P; Chapelle S; Lammens C; Hauchecorne M; Wijdooghe M; Vandamme P; Ieven M; Goossens H
    J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.